drugset / Trial / NCT00964912
Single Dose Study of BMS-820836
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and tolerability of BMS-820836 after single doses
Timeline
- Start
- 2008-07
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liafensine | Small molecule | 0.025 mg | Oral |
| Comparator | Liafensine | Small molecule | 0.1 mg | Oral |
| Comparator | Liafensine | Small molecule | 0.25 mg | Oral |
| Comparator | Liafensine | Small molecule | 0.5 mg | Oral |
| Comparator | Liafensine | Small molecule | 1 mg | Oral |
| Comparator | Liafensine | Small molecule | 2 mg | Oral |
| Comparator | Liafensine | Small molecule | 3 mg | Oral |
| Comparator | Liafensine | Small molecule | 5 mg | Oral |
| Comparator | Liafensine | Small molecule | 8 mg | Oral |